Index 31. Jahrgang, 2012 Inhalte Keywords
Werbung
Herausgeber: M. Spitzer Schriftleitung: P. Brieger A. Ceballos-Baumann S. Evers H. Walter Index 31. Jahrgang, 2012 Inhalte Keywords Schlüsselwörter Autoren http://www.nervenheilkunde-online.de Inhalt – Nervenheilkunde 2012; 31 (1–12) Zu diesem Heft J. Fegert Forensische Psychiatrie des Jugend- und jungen Erwachsenenalters ....................................................................................3 R. Freynhagen Neuropathischer Schmerz, auch eine neurologische Erkrankung?! ..................................................................................102 H.Walter, S. Müller Neurophilosophie und Neuroethik ....................................................................................................................................198 R.Wössner, J. Treib Südwestdeutscher Schlaganfalltag und Review Neurologie in Kaiserslautern ..................................................................199 K. G. Kahl Individualisierte Therapie der Depression – Möglichkeiten und Herausforderungen ...........................................................................................................................................................295 P. P. Urban Klinische Neurophysiologie ...............................................................................................................................................296 A. Villringer Schlaganfall – Prävention, Akuttherapie und Rehabilitation ............................................................................................404 C. Fleischhaker Entwicklungspsychiatrische Aspekte psychischer Erkrankungen vom Kindes- bis ins Erwachsenenalter ..........................490 N. Hopf, Stuttgart Neuroonkologie: besser informiert – besser behandeln ....................................................................................................578 A. Hufnagel Update Neurologie und Psychiatrie ..................................................................................................................................678 G. Breithardt Volkskrankheit Vorhofflimmern ........................................................................................................................................783 A. Ceballos-Baumann, G. Ebersbach Nicht motorische Symptome des idiopathischen Parkinson-Syndroms .............................................................................870 Editorial M. Spitzer Korrupt ist fast jeder – mehr oder weniger ...........................................................................................................................7 Bildung ohne System ........................................................................................................................................................107 Das Pedoskop: Aus der Geschichte kann man lernen! ......................................................................................................203 Groß in Facebook, klein im Gehirn?..................................................................................................................................299 E-Bücher statt Lehrbücher?...............................................................................................................................................407 Digitale Demenz ...............................................................................................................................................................493 Frontalhirn und Fernsehen, Richter und Zucker ................................................................................................................583 Digitale Demenz 2.0 .........................................................................................................................................................681 Big Brother und Cybercrime ..............................................................................................................................................787 Der Kiosk: historisch, systematisch – und neurobiologisch? .............................................................................................875 II http://www.nervenheilkunde-online.de Inhalt – Nervenheilkunde 2012; 31 (1–12) Forensische Psychiatrie M. Allroggen; T. Rau; N. Spröber; J. M. Fegert Sexuelle Gewalt unter Jugendlichen ...................................................................................................................................19 N. Spröber; M. Allroggen; T. Rau; J. M. Fegert Einfluss neuer Medien auf das Vorkommen sexueller Gewalt unter Kindern und Jugendlichen .........................................24 A. Pein; A. Kliemann; D. Schläfke; F. Kupke; A. Wettermann; D. Tardel; J. M. Fegert Profitieren dissoziale Suchtpatienten von der DBT-F?.........................................................................................................30 A. Wettermann; D. Schläfke; F. Kupke; J. M. Fegert Beeinflusst das R&R-Programm neuropsychologische Aspekte bei Straftätern? ...................................................................................................................................................................36 J. Engel; D. Schläfke ADHS in einer Entziehungsmaßregel ..................................................................................................................................42 E. Bastert; D. Schläfke; J. M. Fegert Lernbehinderte und hirnorganisch beeinträchtigte Patienten in der Entziehungsmaßregel ................................................48 Neuropathische Schmerzen S. Schuh-Hofer; R.-D. Treede Definition und Pathophysiologie neuropathischer Schmerzen ..........................................................................................115 R. Rolke; L. Radbruch Screening und Diagnostik neuropathischer Schmerzen.....................................................................................................125 E. Peltz; S. Ott; F. Seifert; C. Maihöfner Funktionelle Bildgebung bei neuropathischen Schmerzen ................................................................................................132 D. Ziegler Schmerzhafte diabetische Polyneuropathie ......................................................................................................................140 M. Förster; F. Mahn; R. Baron Die neuropathische Komponente beim chronischen Rückenschmerz ................................................................................147 M. Fechir; F. Birklein Vom M. Sudeck zum komplex-regionalen Schmerzsyndrom .............................................................................................154 T. R. Tölle; I. Voth; D. Utpadel Therapie neuropathischer Schmerzen ...............................................................................................................................160 Neurophilosophie und Neuroethik M. Christen; M. Regard Der „unmoralische Patient“ .............................................................................................................................................209 H. Krug Das Unzufriedenheitsparadox in der Therapie mit tiefer Hirnstimulation .........................................................................215 K. Witt; L. Timmermann; J. Kuhn; C. Woopen Tiefe Hirnstimulation und personale Identität ..................................................................................................................221 S. M. Fischer Philosophische Kriterien personaler Identität und neurowissenschaft-liche Perspektive ..................................................226 T. Budick; S. T. Vogel; R. J. Jox Therapieentscheidungen bei Wachkoma-Patienten ..........................................................................................................231 J.-H. Heinrichs; U. Langenberg; W. Klitzsch; U. B. Barnikol Neuropsychiatrische Gnadenfrist? ....................................................................................................................................237 S. Ulmer; C. Stippich; O. Jansen; R. v. Kummer; G. Fesl; S. Reiter-Theil Management von Zufallsbefunden in Neuroimaging-Studien...........................................................................................246 III http://www.nervenheilkunde-online.de Inhalt – Nervenheilkunde 2012; 31 (1–12) Südwestdeutscher Schlaganfalltag B. Schumacher; A. Langbein Thrombembolieprophylaxe bei Patienten mit Vorhofflimmern .........................................................................................250 D. Keiner; G. Fischer; J. Oertel Moderne neurochirurgische Behandlungsmöglichkeiten bei Schlaganfall ........................................................................256 S. Klamer; Y. G. Weber; H. Lerche Epilepsie – Wichtige Therapieempfehlungen für die Praxis ..............................................................................................262 Depression T. Hillemacher; J. Wilhelm; A. Heberlein Depression und Alkoholabhängigkeit ...............................................................................................................................305 KW. Sühs; M. Reuther Therapie der Depression bei kardiometabolischen Erkrankungen.....................................................................................311 L. Winter; K. G. Kahl1; A. Wells; U. Schweiger Individualisierte Psychotherapie bei Major Depression .....................................................................................................316 H. Frieling; K. G. Kahl; T. Hillemacher; S. Bleich Epigenetische Veränderungen bei affektiven Störungen...................................................................................................321 Elektrophysiologie W. Graf; H. M. Hamer Elektroenzephalografie .....................................................................................................................................................325 W. Schulte-Mattler; J. Rösl Elektroneurografie ............................................................................................................................................................336 C. Bischoff Elektromyografie ..............................................................................................................................................................341 P. P. Urban Evozierte Potenziale .........................................................................................................................................................346 C.-A. Haensch; S. Isenmann Autonome Funktionsdiagnostik ........................................................................................................................................362 K. Jahn; E. Schneider Untersuchung der vestibulären Funktion bei Schwindelpatienten ....................................................................................370 Parkinson Kompetenznetz Schlaganfall K. G. Häusler; G. Breithardt; M. Endres Schlaganfallprävention bei Vorhofflimmern .....................................................................................................................409 C. H. Nolte Symptomatische Karotisstenose .......................................................................................................................................419 O. C. Singer; J. S. Becktepe; J. Berkefeld Mechanische Rekanalisationstherapien beim akuten Schlaganfall ...................................................................................423 J. Eggers; M. Ohlrich; F. Roessler Sonothrombolyse mit transkraniellem Ultraschall ............................................................................................................428 D. G. Nabavi Intravenöse Thrombolyse bleibt zentrales Behandlungselement ......................................................................................435 H. Hildebrandt; P. Lehmann; A. Kastrup Rehabilitation von Gedächtnisdefiziten nach Hirninfarkt..................................................................................................440 IV http://www.nervenheilkunde-online.de Inhalt – Nervenheilkunde 2012; 31 (1–12) Kinder- und Jugendpsychiatrie M. Biscaldi; R. Rauh; L. Tebartz van Elst; A. Riedel Autismus-Spektrum-Störungen vom Kindes- bis ins Erwachsenenalter ............................................................................498 C. Fleischhaker; E. Schulz Entwicklungspathologie und Verlauf schizophrener Psychosen vom Kindes- bis ins Erwachsenenalter ...........................510 C. Mehler-Wex Entwicklungspsychiatrische Aspekte depressiver Störungen ............................................................................................515 G. Schulte-Körne Diagnostik, Symptomatik und Ursachen der Lese-Rechtschreibstörung............................................................................524 S. Walitza; T. Jans; R. Wettach; H. Zellmann; S. Melfsen; J. Ball Kinder und Jugendliche mit Zwangsstörungen .................................................................................................................530 C. Klein Aufmerksamkeitsdefizit-/Hyperaktivitätsstörungen in der Lebensspanne .........................................................................536 Neuroonkologie M. Renovanz; P. Kohlhof; M. Nadji-Ohl; N. Hopf Hirneigene Tumoren .........................................................................................................................................................587 F. Roser Meningeome ....................................................................................................................................................................599 M. Nadji-Ohl; M. Renovanz; N. Hopf Therapieansätze in der Behandlung von Hirnmetastasen .................................................................................................607 M. W. Münter; H. Welker; K. Keller Radioonkologische Entwicklungen und Behandlungskonzepte neuroonkologischer Tumorerkrankungen .......................615 B. E. Stopschinski; D. Beier; C. P. Beier Medikamentöse Therapie von Hirntumoren......................................................................................................................621 B. Senf; K. Franz; I. Skorka; C. Rödel; J. P. Steinbach; O. Bähr Psychoonkologische Behandlungsindikation und Therapieansätze bei hirneigenen Tumoren .......................................... 630 D. Wiewrodt Psychoonkologische Aspekte bei Patienten mit Hirntumoren ...........................................................................................634 Update Neurologie H. Hefter Update Botulinumtoxintherapie .......................................................................................................................................685 D. Lehmann; S. Zierz Elektrophysiologie, Muskelbiopsie und Molekulargenetik in der Diagnose von Myopathien............................................693 K. G. Kahl Pharmakologische Behandlungsmöglichkeiten bei therapieresistenter Depression ..........................................................699 S. Evers Update Schmerztherapie...................................................................................................................................................709 K. Schröder; C. Klawe; M. Maschke Neurologische und psychiatrische Notfälle .......................................................................................................................718 B. C. Kieseier; C. Warnke; H. Wiendl Immuntherapie heute .......................................................................................................................................................721 C. Schmidt-Kraepelin; B. Janssen Update zur Behandlung schizophrener Erkrankungen ......................................................................................................727 V http://www.nervenheilkunde-online.de Inhalt – Nervenheilkunde 2012; 31 (1–12) Kompetenznetz Vorhofflimmern G. Breithardt; U. Ravens; P. Kirchhof; I. C. van Gelder Vorhofflimmern und Blutungskomplikationen ..................................................................................................................791 A. Müssigbrodt; C. Eitel; G. Hindricks; P. Sommer EKG-Diagnostik von Vorhofflimmern ................................................................................................................................797 A. Gerth; M. Nabauer; T. Limbourg; T. Meinertz; M. Oeff; P. Kirchhof; A. Treszl; K. Wegscheider; G. Breithardt; G. Steinbeck Versorgungswirklichkeit in Deutschland: AFNET-Register ................................................................................................807 S. Zellerhoff; T. Lewalter; L. Eckardt; A. Treszl; K. Wegscheider; G. Breithardt Antithrombotische Therapie bei nicht valvulärem Vorhofflimmern...................................................................................813 P. Kirchhof; D. Gulba, G. Hindricks; A. Goette Leitlinien der Europäischen Gesellschaft für Kardiologie ..................................................................................................821 T. Meinertz; A. Goette; P. Kirchhof; A. Treszl; K. Wegscheider Antiarrhythmische Pharmakotherapie ..............................................................................................................................826 K. G. Häusler; U. Tebbe; S. Willems; C. Sprenger; P. Kirchhof; M. Endres; M. Oeff Neurologische Komplikationen nach linksatrialer Katheterablation bei Vorhofflimmern .................................................830 C. Schneider; A. Storch Parkinson Skalen und Scores zur Erfassung nicht motorischer Symptome beim Morbus Parkinson ..................................................879 W. Jost Kardiovaskuläre Symptome beim idiopathischen Parkinson-Syndrom ..............................................................................884 F. Sixel-Döring; C. Trenkwalder Schlafstörungen bei Morbus Parkinson ............................................................................................................................889 W. N. Vance Miktionsstörungen bei Morbus Parkinson ........................................................................................................................896 F. Gandor; G. Ebersbach Sexuelle Dysfunktion und Hypersexualität bei Morbus Parkinson ....................................................................................904 D. Woitalla; S. Muhlack; O. Götze Gastroenterologische Probleme bei Parkinson-Syndromen...............................................................................................909 A. Ceballos-Baumann; G. Ebersbach Neuropsychiatrische Störungen bei der Parkinson-Erkrankung.........................................................................................915 VI http://www.nervenheilkunde-online.de Inhalt – Nervenheilkunde 2012; 31 (1–12) Original- und Übersichtsarbeiten M. Nagel; S. Koenecke; B. Willenborg; M. Penshorn; E. Gorsky-Ostmeier; W. Tigges; H. Tigges; U. Schweiger Magenmodulierende Operationen bei Patienten mit Adipositas und psychiatrischen Komorbiditäten ...............................55 A. Meißner Omega-3-Fettsäuren in der Psychiatrie ...............................................................................................................................61 M. Gahr; R. W. Freudenmann; C. Hiemke; I. M. Gunst; B. J. Connemann; C. Schönfeldt-Lecuona „Krokodil“ – eine neue Droge? ..........................................................................................................................................69 N. D. Wolf; T. Leménager; F. Kiefer Baclofen bei Alkoholabhängigkeit ....................................................................................................................................164 J. Rösche; A. Schley; R. Benecke Neuropsychologisches Screening in einer epileptologischen Spezialsprechstunde ...........................................................171 S. Erbe; T. Bschor Non-Response auf eine Antidepressiva-Monotherapie .....................................................................................................175 R.-D. Kocalevent; K. Holtz; M. Schützwohl; A.-G. Müller; A. Bramesfeld; U. Hegerl; S. Boenisch-Alert Bedarfsanalyse für Kinder psychisch kranker Eltern in Nervenarztpraxen .........................................................................272 J. Lemcke; U. Meier Idiopathischer Normaldruckhydrozephalus .......................................................................................................................446 J. Streb; K. Hille; S. Schoch; Z. Sosic-Vasic Aufmerksamkeitstraining fördert exekutive Funktionen von Kindergartenkindern ...........................................................450 S. Becker; F. A. Muthny Coping mit Krebs ..............................................................................................................................................................455 C. Lohr; A.-K. Fladung Stress, Emotionsregulation und Essstörungsrisiko in der Adoleszenz ...............................................................................461 U. Meier; J. Lemcke Klinische Symptomatik und Diagnostik des idiopathischen Normaldruckhydrozephalus ..................................................543 M. Bürgy Zukunft der Sozialpsychiatrie ............................................................................................................................................549 U. Meier; J. Lemcke Therapie und Prognose des iNPH......................................................................................................................................640 A. Pabst; J. Aldenhoff; M. Schauer; M. Ruf; T. Elbert; M. Seeck-Hirschner Borderline-Störungen mit komorbider posttraumatischer Belastungsstörung...................................................................645 M. D. Heidler Uhrentest bei Patienten mit schwerer Aphasie .................................................................................................................837 B. A. Kuchinke; B. Akmaz; W. Janetzky Kostenaspekte der frühen Diagnose und Pharmakotherapie beim Morbus Parkinson ......................................................844 D. Hirjak; A. Bechdolf; P. A. Thomann; U. Thiemann; R. C. Wolf Indizierte Prävention psychotischer Störungen .................................................................................................................923 M. Michal; I. Tavlaridou; C. Subic-Wrana; M. E. Beutel Angst verrückt zu werden .................................................................................................................................................934 L. Fischer; J. M. Fegert; M. Kölch; R. Kleinrahm; N. Spröber Goal Attainment Scaling ...................................................................................................................................................939 Kasuistik M. Gahr; A. Akdag; C. Schönfeldt-Lecuona Antriebsstörung und Verhaltensauffälligkeiten bei Makroprolactinom.............................................................................758 VII http://www.nervenheilkunde-online.de Inhalt – Nervenheilkunde 2012; 31 (1–12) Leitlinie A. Straube; B. Hinz; P. Kropp; S. Förderreuther; C. Lampl; P. Sandor; A. May; G. Haag Kopf- und Gesichtsschmerzen im Alter .............................................................................................................................733 Geist und Gehirn M. Spitzer Imitieren und/oder Improvisieren(?) .................................................................................................................................180 Kommunikation ................................................................................................................................................................278 Vom Geigen zum Physikum ..............................................................................................................................................378 Das politische Gehirn ........................................................................................................................................................467 Oxytocin – die dunkle Seite des Kuschelhormons .............................................................................................................653 Soziale Schmerzen ............................................................................................................................................................761 Lesen und Schreiben .........................................................................................................................................................850 Gedächtnisspuren löschen? ..............................................................................................................................................944 VIII http://www.nervenheilkunde-online.de Keywords – Nervenheilkunde 2012; 31 (1–12) acute ischemic stroke...................................428 acute stroke .................................................423 adaptability ..................................................455 addicted criminal offenders......................30, 36 ADHD .....................................................42, 536 adolescence .................................................461 adolescents ..............................................19, 24 AF burden ....................................................797 alcohol dependence .............................164, 305 alertness ......................................................171 allodynia ......................................................115 Alzheimer's disease ...............................61, 237 antiarrhythmic drug therapy ........................826 anticoagulant therapy ..................................821 anticoagulation ....................................409, 807 antidepressants............................175, 311, 515 antiepileptic drugs .......................................263 antipsychotics ..............................................727 antisocial patients ..........................................30 antithrombotic therapy ................................813 aphasia ........................................................837 Apixaban .....................................................250 apraxia .........................................................837 atrial fibrillation ..................250, 791, 797, 807, ...................................813, 821, 826, 830 attention ......................................................450 attention deficit disorder..............................450 auditory evoked potentials ..........................346 augmentation ..............................................699 autonomic testing ........................................362 baclofen .......................................................164 bariatric surgery .............................................55 bladder dysfunction .....................................896 blood Pressure .............................................884 blood pressure regulation ............................362 Borderline personality disorder ..............61, 645 brain metastases ..........................................607 brain radiotherapy .......................................607 brain tumor ..................................621, 634, 758 brain tumors ................................................615 braintumor ...................................................587 calorics .........................................................370 cancer ..........................................................455 candidate genes ...........................................524 CAP/COL-concept .........................................685 carotid angioplasty ......................................419 carotid endarteriectomy ...............................419 carotid occlusion ..........................................256 carotid stenting ............................................419 catheter ablation..........................................830 causalgia ......................................................154 causes ..........................................................536 CBASP ..........................................................316 cerebral infarction ........................................435 cerebral revascularization ............................256 chemotherapy ..............................599, 607, 621 child development .......................................450 children ..........................................................24 children of mentally ill parents.....................272 chronic low back pain ..................................147 clock test......................................................837 combination .................................................699 community psychiatry .................................. 549 comorbidity ................................................. 498 complex traumatisation ............................... 645 complications ...................................... 791, 830 comprehensive therapy ............................... 826 coping.......................................................... 455 cortical reorganization ................................. 132 course .......................................................... 536 craving......................................................... 164 CRPS ............................................................ 154 dabigatran ................................................... 250 DBT-F ............................................................. 30 decompressive craniectomy ......................... 256 deep brain stimulation......................... 215, 221 deep neck muscles....................................... 685 de-hospitalisation ........................................ 549 delinquency ................................................... 42 dementia ............................................. 797, 915 depersonalization ........................................ 934 depot formulations ...................................... 727 depression ..... 61, 175, 305, 311, 321, 758, 915 derealization ................................................ 934 Desomorphine ............................................... 69 developmental psychiatry ............................ 515 Diabetes mellitus ......................................... 311 diagnosis ............................................. 524, 821 diagnostics .................................................. 587 dimensionality ............................................. 455 direct costs .................................................. 844 DN4 ............................................................ 125 DNA methylation ......................................... 321 dopaminergics ............................................. 915 dyslexia ....................................................... 524 early intervention ........................................ 923 early onset OCD ........................................... 530 early Onset Schizophrenia (EOS) .................. 510 ECG monitoring ........................................... 797 ECG-recording ............................................. 409 EEG ............................................................ 325 effectiveness of psychotherapy .................... 939 elderly patient ............................................. 733 electrical remodeling ................................... 826 electrophysiology......................................... 693 embolism ..................................................... 791 emergency ................................................... 718 EMG ............................................................ 341 emotion regulation ...................................... 461 encephalopathy ........................................... 325 endovascular treatment ............................... 423 enteric nervous system ................................ 909 epidemiology ............................................... 733 epigenetics .................................................. 321 epilepsy ............................................... 263, 325 ethics ........................................................... 246 evaluation.................................................... 939 executive functions ...................... 171, 837, 450 extracranial-intracranial bypass ................... 256 facial neuralgia ............................................ 733 factor Xa antagonist .................................... 409 focused ........................................................ 645 follow-up study ........................................... 530 forensic psychiatry ......................................... 42 frontal lesions ............................................. 209 functional imaging ...................................... 132 functioning .................................................. 498 future prospects .......................................... 549 gait ataxia ................................................... 543 gastrointestinal symptoms .......................... 909 German AFNET registry ............................... 807 glioblastoma ............................................... 621 glioma ................................................. 587, 630 goal attainment scaling............................... 939 gravitational valve ...................................... 640 guidelines ............................................ 160, 807 Hakim triad ................................................. 543 hallucinations .............................................. 915 head impulse test ........................................ 370 headache..................................................... 709 health care services ..................................... 727 heart rate .................................................... 884 heart rate variability .................................... 362 heroin ............................................................ 69 high-functioning autism spectrum disorders ............................................. 498 hydrodynamic concept ................................ 446 hyperalgesia ................................................ 115 hypersexuality ............................................. 904 IDH1 ........................................................... 621 idiopathic normal pressure hydrocephalus ..................... 446, 543, 640 immunomodulation ..................................... 721 Immunopathogenesis .................................. 721 immunosuppression .................................... 721 impulse control disorders ............................ 915 iMRT ........................................................... 615 incidental findings ....................................... 246 individual identity ....................................... 221 infarction ..................................................... 311 internal carotid artery stenosis .................... 419 interventional treatment ............................. 709 invasive diagnostics .................................... 543 judgments ................................................... 231 LANSS ......................................................... 125 law ........................................................... 231 learning disability .......................................... 48 lithium augmentation.................................. 175 LOH 1p/19q ................................................. 621 long-term course ......................................... 498 long-term surviving ..................................... 630 major depression ......................................... 515 mechanical recanalization ........................... 423 mechanism-based therapy .......................... 160 medicinal treatment .................................... 844 memory disorder ......................................... 440 meningioma ................................................ 599 mental retardation ........................................ 48 metacognitive therapy ................................ 316 MGMT ......................................................... 621 MIBG-scintiscan .......................................... 884 microsurgery ............................................... 599 mindfulness-based cognitive therapy .......... 316 minimal-invasive-surgical technique ........... 256 molecular genetics ...................................... 693 monoclonal antibodies ................................ 721 IX http://www.nervenheilkunde-online.de Keywords – Nervenheilkunde 2012; 31 (1–12) moral science ...............................................209 morphine .......................................................69 motor evoked potentials ..............................346 motor nerve conduction studies ...................336 motor unit potentials ...................................341 muscle biopsy ..............................................693 muscle diseases ...........................................693 myocardial ...................................................311 narration ......................................................226 narrative exposure therapy ..........................645 needs ...........................................................272 neurasthenia ................................................758 neurodeterminism ........................................209 neuroethics ..........................................209, 237 neuroimaging...............................................246 neurology .....................................................718 neuronal plasticity .......................................132 neuronal states ............................................226 neurooncology .....................................621, 634 neuropathic pain .........................115, 125, 132, ...........................................147, 160, 709 neuropsychological deficits ............................36 neuropsychology ..........................................440 new media .....................................................24 nociceptor ....................................................115 non-dipper ...................................................884 non-motor symptoms ...................................879 non-pharmacological treatment...................140 NPQ ............................................................125 obesity-surgery ..............................................55 OCD in childhood and adolescence ..............530 off-label use .................................................515 omega 3 fatty acids .......................................61 online support ..............................................272 opioids .........................................................709 organic brain disorder ....................................48 organic mental disorder ...............................758 orthostatic hypotension ...............................884 otolith testing ..............................................370 pain questionnaire .......................................125 pain therapy .................................................709 painDETECT .................................................125 painful diabetic neuropathy .........................140 paradox of dissatisfaction ............................215 paranoid schizophrenia ................................934 parental mental illness .................................272 Parkinson´s disease .............844, 879, 884, 889, ...................................896, 904,909, 915 particle therapy ............................................615 pathogenesis................................................587 pathophysiology .......................................... 446 patient-doctor-relation ................................ 237 people with chronic mental disorder ........... 549 perpetrator .................................................... 19 personal identity .................................. 221, 226 personality ................................................... 221 pharmaco- ................................................... 140 polytherapy.................................................. 171 possible ....................................................... 844 posttraumatic stress disorder ...................... 645 prevalence ................................................... 791 prevalence of neutralizing antibodies .......... 685 prevention ........................................... 237, 305 primary brain tumor .................................... 630 primary headaches ...................................... 733 prodrome ..................................................... 923 Prognosis ............................................... 48, 640 prognostic evaluation .................................... 30 prolactinoma ............................................... 758 psychiatric care ............................................ 549 psychiatric disorder........................................ 55 psychiatry .................................................... 718 psychooncology ................................... 630, 634 psychoses ...................................................... 61 psychosis ..................................................... 923 psychosocial adaptation .............................. 530 psychosocial distress ................................... 630 psychotherapy ..................................... 305, 699 QST ............................................................ 125 quality of Life....................................... 215, 498 quantitative sensory testing ................ 125, 160 questionnaire............................................... 879 R&R program ................................................. 36 radiosurgery ................................................ 599 radiotherapy ........................................ 607, 615 rate control .................................................. 821 recruitment .................................................. 341 rehabilitation ............................................... 440 relapse ......................................................... 305 repetitive nerve stimulation ......................... 336 responsible management ............................ 246 restrictive eating .......................................... 461 rhythm control ............................................. 821 rhythm control therapy ................................ 409 risk factors ................................................... 791 risk markers ................................................. 791 savings ........................................................ 844 schizophrenia .............................. 510, 727, 923 schizophrenic psychoses .............................. 510 school type .................................................. 461 scientific relevance ...................................... 226 screening instruments ................................. 634 secondary headaches .................................. 733 sensory nerve conduction studies................ 336 sexual aggression .................................... 19, 24 sexual dysfunction....................................... 904 silent atrial fibrillation ................................. 797 sleep disorders ............................................ 889 social psychiatry .......................................... 549 social skills training ..................................... 498 somatosensory evoked potentials ............... 346 spastic arm position patterns ...................... 685 spontaneous activity ................................... 341 status epilepticus ........................................ 325 stereotactic radiosurgery ............................. 615 stroke ......................... 250, 311, 435, 440, 791, .................................. 797, 813, 821, 830 stroke prevention ........................................ 821 subjective visual vertical ............................. 370 substance dependence .................................. 69 sudomotor ................................................... 362 surgical therapy ........................................... 587 SVASONA study .......................................... 640 switching ..................................................... 699 sympathetic maintained pain ...................... 154 sympathetic reflex dystro-phia .................... 154 symptomatolgy ........................................... 733 symptomatology ......................................... 524 syncope ....................................................... 362 temozolomide ............................................. 621 therapy ................ 140, 147, 428, 607, 718, 733 therapy resistance ....................................... 175 thrombin inhibitor ....................................... 409 thrombolysis........................................ 428, 435 transcranial ultrasound ............................... 428 trauma ........................................................ 645 treatment ............................................ 263, 536 treatment-resistant depression.................... 699 vascular dementia ....................................... 440 vegetative state........................................... 231 ventriculoperitoneal shunt .......................... 640 very Early Onset Schizophrenia (VEOS) ....... 510 victim ............................................................ 19 video-oculography....................................... 370 video-supported polysomnography ............. 889 visually evoked potentials ........................... 346 vocational disintegration............................. 171 warfarin ...................................................... 250 watchman device ........................................ 250 web-based assessment ............................... 164 X http://www.nervenheilkunde-online.de Schlüsselwörter – Nervenheilkunde 2012; 31 (1–12) älterer und alter Patient ...............................733 achtsamkeitsbasierte kognitive Therapie .....316 Adaptivität ...................................................455 ADHS .....................................................42, 536 Adipositaschirurgie ........................................55 Adoleszenz...................................................461 AFNET-Register ............................................807 akustisch evozierte Potenziale .....................346 akuter ischämischer Schlaganfall .................428 akuter Schlaganfall ......................................423 Alkoholabhängigkeit ............................164, 305 Allodynie ......................................................115 Alzheimer-Demenz .........................................61 antiarrhythmische Pharmakotherapie ..........826 Antidepressiva .............................175, 311, 515 Antikoagulation ...................409, 807, 813, 821 Antikonvulsiva .............................................263 Antipsychotika .............................................727 Aphasie ........................................................837 Apixaban .....................................................250 Apraxie ........................................................837 Arbeitslosigkeit ............................................171 Armspastikmuster ........................................685 arteria-carotis-interna-Stenose ....................419 Aufmerksamkeit...........................................450 Aufmerksamkeitsdefizitstörung ...................450 Aufmerksamkeitsfunktionen ........................171 Augmentation ..............................................699 autonome Funktionsuntersuchung...............362 Baclofen .......................................................164 bariatrische Operation ...................................55 Bedarf ..........................................................272 Behandlung..................................................536 Berufsunfähigkeit.........................................171 Blutdruck .....................................................884 Blutdruckregulation .....................................362 Borderline-Persönlichkeitsstörung .........61, 645 CAP/COL-Konzept ........................................685 CBASP ..........................................................316 Chemotherapie ............................599, 607, 621 chronisch psychisch Kranke .........................549 chronischer Rückenschmerz .........................147 Coping .........................................................455 CRPS ............................................................154 Dabigatran ...................................................250 DBT-Forensik ..................................................30 Dekompressionskraniektomie ......................256 Delinquenz .....................................................42 Demenz ........................................................915 Demenz vom Alzheimer Typ (DAT) ...............237 Depersonalisation ........................................934 Depotpräparate ............................................727 Depression .....61, 175, 305, 311, 321, 758, 915 depressive Störungen ...................................515 Derealisation ................................................934 Desomorphin .................................................69 Diabetes mellitus .........................................311 Diagnose ......................................................821 Diagnostik ....................................147, 524, 587 Dimensionalität............................................455 direkte Kosten ..............................................844 Dissozialität ...................................................30 DN4 ............................................................ 125 DNA-Methylierung....................................... 321 Dopaminergika ............................................ 915 Early Onset Schizophrenia (EOS).................. 510 EEG ............................................................ 325 Einsparpotenziale ........................................ 844 EKG-Diagnostik ........................................... 409 elektrisches Remodeling .............................. 826 Elektrophysiologie ....................................... 693 elterliche Psychopathologie ......................... 272 Embolie ....................................................... 791 EMG ............................................................ 341 Emotionsregulation ..................................... 461 endarteriektomie ......................................... 419 endovaskuläre Therapie............................... 423 enterisches Nervensystem ........................... 909 Enthospitalisierung ...................................... 549 Entwicklungspsychiatrie .............................. 515 Entziehungsmaßregel .............................. 30, 36 Enzephalopathie .......................................... 325 Epigenetik.................................................... 321 Epilepsie .............................................. 263, 325 Ethik ............................................................ 246 Evaluation ................................................... 939 exekutive Funktionen .......................... 171, 450 Exekutivfunktionen ...................................... 837 extrakranieller-intrakranieller Bypass .......... 256 Faktor-Xa-Antagonisten .............................. 409 forensische Psychiatrie .................................. 42 Fragebogen ................................................. 879 Frequenz- und Rhythmuskontrolle ............... 821 frontale Läsionen ......................................... 209 Frühbehandlung .......................................... 923 funktionelle Bildgebung .............................. 132 Funktionsniveau .......................................... 498 Gangataxie .................................................. 543 Ganzhirnbestrahlung ................................... 607 gastrointestinal Symptome .......................... 909 Gedächtnisstörung ...................................... 440 Gemeindepsychiatrie ................................... 549 Gesichtsschmerzen ...................................... 733 Glioblastom ................................................. 621 Gliom ................................................... 587, 630 Goal Attainment Scaling .............................. 939 Gravitationsventil ........................................ 640 Hakim-Trias ................................................. 543 Halluzination ............................................... 915 Harnblasenfunktionsstörungen .................... 896 Häufigkeit .................................................... 733 Heroin ............................................................ 69 Herzfrequenz ............................................... 884 Herzfrequenzvariabilität .............................. 362 hirneigene Tumoren .................................... 587 Hirninfarkt ................................................... 435 Hirnmetastase ............................................. 607 hirnorganische Beeinträchtigung ................... 48 Hirntumor .................... 615, 621, 630, 634, 758 hochfunktionale Autismus-SpektrumStörungen............................................ 498 hydrodynamisches Konzept ......................... 446 Hyperalgesie ................................................ 115 Hypersexualität............................................ 904 IDH1 ........................................................... 621 idiopathischer Normaldruckhydrozephalus ..................... 446, 543, 640 idiopathisches Parkinson-Syndrom .............. 915 Immunmodulation ....................................... 721 Immunpathogenese .................................... 721 Immunsuppression ...................................... 721 Impulskontrollstörung ................................. 915 IMRT ........................................................... 615 individuelle Identität ................................... 221 Intelligenzminderung .................................... 48 Internetbefragung ....................................... 164 interventionelle Verfahren ........................... 709 invasive Diagnostik ..................................... 543 Jugendliche ............................................. 19, 24 Kalorik ......................................................... 370 Kandidatengene .......................................... 524 Karotisangioplasie ....................................... 419 Karotisstenose ............................................. 256 Karotisstenting ............................................ 419 Katheterablation ......................................... 830 Kausalgie .................................................... 154 Kinder............................................................ 24 Kinder psychisch erkrankter Eltern .............. 272 Kindesentwicklung ...................................... 450 Kombination................................................ 699 Komorbidität ............................................... 498 komplexe Traumatisierung .......................... 645 Komplikationen ................................... 791, 830 Kopfimpulstest ............................................ 370 Kopfschmerzen ............................................ 709 kortikale Reorganisation ............................. 132 Krankheitsverarbeitung ............................... 455 Langzeitüberleben ....................................... 630 Langzeitverlauf ............................................ 498 LANSS ......................................................... 125 Lebensqualität..................................... 215, 498 Leitlinien ............................................. 160, 807 Lernbehinderung ........................................... 48 Lese-Rechtschreibstörung............................ 524 Lithiumaugmentation .................................. 175 LOH 1p/19q ................................................. 621 Marcumar.................................................... 250 mechanische Rekanalisation ....................... 423 medikamentöse Behandlung ....................... 844 Meningeom ................................................. 599 metakognitive Therapie............................... 316 MGMT ......................................................... 621 MIBG-Szintigrafie ........................................ 884 Mikrochirurgie ............................................. 599 minimal-invasive Technik ............................ 256 Molekulargenetik ........................................ 693 monoklonale Antikörper.............................. 721 Moralforschung ........................................... 209 Morbus Parkinson ....... 844, 879, 889, 896, 904 Morphin ........................................................ 69 motorisch evozierte Potenziale ................... 346 motorische Neurografie............................... 336 Muskelbiopsie ............................................. 693 Muskelerkrankungen................................... 693 Myokardinfarkt ........................................... 311 Narration ..................................................... 226 XI http://www.nervenheilkunde-online.de Schlüsselwörter – Nervenheilkunde 2012; 31 (1–12) narrative Expositionstherapie ......................645 neue Medien ..................................................24 Neuralgien ...................................................733 Neurasthenie ...............................................758 Neurodeterminismus ....................................209 Neuroethik ...........................................209, 237 Neuroimaging ..............................................246 Neurologie ...................................................718 neuronale Zustände .....................................226 Neuroonkologie ...................................621, 634 neuropathischer Schmerz ............115, 125, 132, ...........................................147, 160, 709 Neuroplastizität ...........................................132 Neuropsychologie ........................................440 neuropsychologische Defizite .........................36 neurowissenschaftliche Relevanz .................226 nicht motorische Symptome.........................879 nicht pharmakologische Therapie ................140 Non-dipper ...................................................884 Notfall ..........................................................718 Nozizeptor ...................................................115 NPQ ............................................................125 Off-label-Gebrauch ......................................515 Omega-3-Fettsäuren ......................................61 Online-Hilfsangebote ...................................272 operative Therapie .......................................587 Opfer ..............................................................19 Opioide ........................................................709 organische psychische Störung ....................758 orientierte Therapie .....................................160 orthostatische Hypotonie .............................884 Otolithentestung ..........................................370 painDETECT .................................................125 paranoide Schizophrenie ..............................934 Parkinson-Syndrom ..............................884, 909 Pathogenese ................................................587 pathologische Spontanaktivität ...................341 Pathophysiologie .........................................446 Patient-Arzt-Beziehung ................................237 personale Identität ...............................221, 226 Persönlichkeit ..............................................221 Pharmakotherapie .......................................140 Polysomnografie ..........................................889 Polytherapie .................................................171 posttraumatische Belastungsstörung ...........645 Potenzialanalyse ..........................................341 Prävalenz .....................................................791 Prävalenz neutralisierender Antikörper ........685 primäre Kopfschmerzen ............................... 733 Prodrom....................................................... 923 Prognose ..................................................... 640 Prognosebeurteilung ..................................... 30 Prognosen ..................................................... 48 Prolactinom ................................................. 758 Psychiatrie ................................................... 718 psychiatrische Versorgung ........................... 549 psychische Störung ........................................ 55 Psychoonkologie .................................. 630, 634 Psychose ................................................ 61, 923 psychosoziale Anpassung ............................ 530 psychosoziale Belastungen .......................... 630 Psychotherapie .................................... 305, 699 QST ............................................................ 125 quantitative sensorische Testung ........ 125, 160 R&R-Programm.............................................. 36 Radiochirurgie ............................................. 607 Radiotherapie .............................................. 615 Rechtslage ................................................... 231 Rehabilitation .............................................. 440 Rekrutierungsverhalten motorischer Einheiten ............................................. 341 repetitive Nervenstimulation ....................... 336 restriktives Essverhalten .............................. 461 Revaskularisation ........................................ 256 Risikofaktoren ............................................. 791 Risikomarker................................................ 791 Rückfallprophylaxe ...................................... 305 schizophrene Psychosen .............................. 510 Schizophrenie .............................. 510, 727, 923 Schlafstörungen ........................................... 889 Schlaganfall ................. 311, 435, 791, 813, 830 Schlaganfallprävention ........................ 409, 821 Schmerzfragebogen ..................................... 125 schmerzhafte diabetische Neuropathie........ 140 Schmerztherapie .......................................... 709 Schulart ....................................................... 461 Screening-Methoden ................................... 634 sekundäre Kopfschmerzen ........................... 733 sensible Neurografie .................................... 336 sexuelle Aggression ................................. 19, 24 sexuelle Dysfunktion.................................... 904 somatosensorisch evozierte Potenziale ....... 346 Sozialpsychiatrie .......................................... 549 Status epilepticus ........................................ 325 stereotaktische Radiotherapie ..................... 615 Strahlentherapie .......................................... 599 subjektive visuelle Vertikale ........................ 370 Substanzabhängigkeit ................................... 69 Suchtdruck .................................................. 164 Sudomotorik ................................................ 362 SVASONA-Studie ......................................... 640 Switching .................................................... 699 sympathisch unterhaltener Schmerz ............ 154 sympathische Reflexdystrophie ................... 154 Symptomänderung ...................................... 733 Symptomatologie ........................................ 524 Synkope ...................................................... 362 Täter ............................................................. 19 Teilchentherapie .......................................... 615 Temozolomid............................................... 621 Therapie .............. 147, 263, 428, 718, 733, 826 therapieresistente Depression ..................... 699 Therapieresistenz ........................................ 175 Thrombembolieprophylaxe .......................... 250 Thrombininhibitoren.................................... 409 Thrombolyse ........................................ 428, 435 Tiefe Hirnstimulation ........................... 215, 221 tiefe Nackenmuskulatur .............................. 685 Training der sozialen Kompetenzen ............ 498 transkranieller Ultraschall ........................... 428 traumafokussierte Verfahren ....................... 645 Uhrentest .................................................... 837 Unzufriedenheitsparadoxon ........................ 215 Ursachen ..................................................... 536 Urteile ......................................................... 231 vaskuläre Demenz ....................................... 440 ventrikuloperitonealer Shunt ....................... 640 verantwortungsvolles Management ............ 246 Verlauf ................................................ 530, 536 Verlaufsstudien ........................................... 530 Versorgung .................................................. 727 Very Early Onset Schizophrenia (VEOS) ....... 510 Videookulografie ......................................... 370 visuell evozierte Potenziale ......................... 346 Vorhofflimmern .......... 250, 409, 791, 807, 813, ......................................... 821, 826, 830 Vorhofohrverschluss .................................... 250 Vorsorge ...................................................... 237 Wachkoma .................................................. 231 Wirksamkeitsforschung ............................... 939 Zufallsbefunde ............................................ 246 Zukunftsperspektiven .................................. 549 Zwangsstörungen im Kindes- und Jugendalter ......................................... 530 XII http://www.nervenheilkunde-online.de Autoren – Nervenheilkunde 2012; 31 (1–12) Akdag, A. .....................................................758 Akmaz, B. ....................................................844 Aldenhoff, J. .................................................645 Allroggen, M. ...........................................19, 24 Bähr, O.........................................................630 Ball, J. ..........................................................530 Barnikol, U. B. ..............................................237 Baron, R. ......................................................147 Bastert, E. ......................................................48 Bechdolf, A. .................................................923 Becker, S. .....................................................455 Becktepe, J. S. ..............................................423 Beier, C. P. ...................................................621 Beier, D. .......................................................621 Benecke, R. ..................................................171 Berkefeld, J. .................................................423 Beutel, M. E. ................................................934 Birklein, F. ....................................................154 Biscaldi, M. ..................................................498 Bischoff, C....................................................341 Bleich, S. ......................................................321 Boenisch-Alert, S..........................................272 Bonenberger, M. ..........................................761 Bramesfeld, A. .............................................272 Breithardt, G. ...............409, 791, 807, 813, 783 Bschor, T. .....................................................175 Budick, T. .....................................................231 Bürgy, M. .....................................................549 Ceballos-Baumann, A. .........................915, 870 Christen, M. .................................................209 Connemann, B. J. ...........................................69 Ebersbach, G. ...............................904, 915, 870 Eckardt, L. ....................................................813 Eggers, J.......................................................428 Eitel, C. ........................................................797 Elbert, T. ......................................................645 Endres, M. ............................................409, 830 Engel, J. .........................................................42 Erbe, S..........................................................175 Evers, S. .......................................................709 Fechir, M. .....................................................154 Fegert, J. M. ...............19, 24, 30, 36, 48, 3, 939 Fesl, G. .........................................................246 Fischer, G. ....................................................256 Fischer, L. .....................................................939 Fischer, S. M. ...............................................226 Fladung, A. -K ..............................................461 Fleischhaker, C. ....................................510, 490 Förderreuther, S. ..........................................733 Förster, M. ...................................................147 Franz, K. .......................................................630 Freudenmann, R. W. ......................................69 Freynhagen, R. .............................................102 Frieling, H. ...................................................321 Gahr, M. ................................................69, 758 Gandor, F. ....................................................904 Gerth, A. ......................................................807 Goette, A. ............................................821, 826 Gorsky-Ostmeier, E. .......................................55 Götze, O. ......................................................909 Graf, W. .......................................................325 Gulba, D. ......................................................821 Gunst, I. M..................................................... 69 Haag, G. ...................................................... 733 Haensch, C. -A ............................................. 362 Hamer, H. M. ............................................... 325 Häusler, K. G........................................ 409, 830 Heberlein, A. ................................................ 305 Hefter, H. ..................................................... 685 Hegerl, U. .................................................... 272 Heidler, M. D. .............................................. 837 Heinrichs, J. -H ............................................. 237 Hiemke, C. ..................................................... 69 Hildebrandt, H. ............................................ 440 Hille, K. ........................................................ 450 Hillemacher, T...................................... 305, 321 Hindricks, G. ........................................ 797, 821 Hinz, B. ........................................................ 733 Hirjak, D. ..................................................... 923 Holtz, K. ....................................................... 272 Hopf, N. ....................................... 587, 607, 578 Hufnagel, A. ................................................ 678 Isenmann, S. ................................................ 362 Jahn, K. ........................................................ 370 Janetzky, W. ................................................ 844 Jans, T. ........................................................ 530 Jansen, O. .................................................... 246 Janssen, B. ................................................... 727 Jost, W. ........................................................ 884 Jox, R. J........................................................ 231 Kahl, K. G. ........................... 316, 321, 295, 699 Kastrup, A.................................................... 440 Keiner, D. ..................................................... 256 Keller, K. ...................................................... 615 Kiefer, F. ...................................................... 164 Kieseier, B. C. .............................................. 721 Kirchhof, P. .................. 791, 807, 821, 826, 830 Klamer, S. .................................................... 263 Klawe, C. ..................................................... 718 Klein, C. ....................................................... 536 Kleinrahm, R. ............................................... 939 Kliemann, A. .................................................. 30 Klitzsch, W. .................................................. 237 Kocalevent, R. -D ......................................... 272 Koenecke, S. .................................................. 55 Kohlhof, P. ................................................... 587 Kölch, M. ..................................................... 939 Kropp, P. ...................................................... 733 Krug, H. ....................................................... 215 Kuchinke, B. A. ............................................ 844 Kuhn, J......................................................... 221 Kummer, R. v. .............................................. 246 Kupke, F. ................................................. 30, 36 Lampl, C. ..................................................... 733 Langbein, A. ................................................ 250 Langenberg, U. ............................................ 237 Lehmann, D. ................................................ 693 Lehmann, P.................................................. 440 Lemcke, J. .................................... 446, 543, 640 Leménager, T. .............................................. 164 Lerche, H. .................................................... 263 Lewalter, T. .................................................. 813 Limbourg, T. ................................................ 807 Löhr, C. ........................................................ 461 Mahn, F. ...................................................... 147 Maihöfner, C. .............................................. 132 Maschke, M. ............................................... 718 May, A......................................................... 733 Mehler-Wex, C. ........................................... 515 Meier, U. ..................................... 446, 543, 640 Meinertz, T. ......................................... 807, 826 Meißner, A. ................................................... 61 Melfsen, S. .................................................. 530 Michal, M. ................................................... 934 Muhlack, S. ................................................. 909 Müller, A. -G ............................................... 272 Müller, S. ..................................................... 198 Münter, M. W. ............................................. 615 Müssigbrodt, A. ........................................... 797 Muthny, F. A. .............................................. 455 Nabauer, M. ................................................ 807 Nabavi, D. G. ............................................... 435 Nadji-Ohl, M. ...................................... 587, 607 Nagel, M. ...................................................... 55 Nolte, C. H................................................... 419 Oeff, M. ............................................... 807, 830 Oertel, J. ...................................................... 256 Ohlrich, M. .................................................. 428 Ott, S. .......................................................... 132 Pabst, A. ...................................................... 645 Pein, A........................................................... 30 Peltz, E. ....................................................... 132 Penshorn, M. ................................................. 55 Radbruch, L. ................................................ 125 Rau, T. ..................................................... 19, 24 Rauh, R. ...................................................... 498 Ravens, U. ................................................... 791 Regard, M. .................................................. 209 Reiter-Theil, S. ............................................. 246 Renovanz, M. ...................................... 587, 607 Reuther, M. ................................................. 311 Riedel, A. ..................................................... 498 Rödel, C....................................................... 630 Roessler, F. .................................................. 428 Rolke, R. ...................................................... 125 Rösche, J. .................................................... 171 Roser, F. ...................................................... 599 Rösl, J. ......................................................... 336 Ruf, M. ........................................................ 645 Sandor, P. .................................................... 733 Schauer, M. ................................................. 645 Schläfke, D. ................................. 30, 36, 42, 48 Schley, A. .................................................... 171 Schmidt-Kraepelin, C. .................................. 727 Schneider, C. ............................................... 879 Schneider, E. ............................................... 370 Schoch, S. .................................................... 450 Schönfeldt-Lecuona, C........................... 69, 758 Schröder, K. ................................................. 718 Schuh-Hofer, S............................................. 115 Schulte-Körne, G. ........................................ 524 Schulte-Mattler, W. ..................................... 336 Schulz, E. ............................................. 510, 490 Schumacher, B. ........................................... 250 Schützwohl, M. ........................................... 272 Schweiger, U. ........................................ 55, 316 XIII http://www.nervenheilkunde-online.de Autoren – Nervenheilkunde 2012; 31 (1–12) Seeck-Hirschner, M. .....................................645 Seifert, F.......................................................132 Senf, B. ........................................................630 Singer, O. C. .................................................423 Sixel-Döring, F..............................................889 Skorka, I. ......................................................630 Sommer, P. ..................................................797 Sosic-Vasic, Z. ..............................................450 Spitzer, M................7, 180, 107, 278, 203, 378, ..................299, 467, 407, 493, 653, 583, ...................761, 681, 787, 850, 875, 944 Sprenger, C. .................................................830 Spröber, N. .......................................19, 24, 939 Steinbach, J. P. .............................................630 Steinbeck, G. ................................................807 Stippich, C. ...................................................246 Stopschinski, B. E. ........................................621 Storch, A. .....................................................879 Straube, A. ...................................................733 Streb, J. ........................................................450 Subic-Wrana, C. ...........................................934 Sühs, K. W....................................................311 Tardel, D. .......................................................30 Tavlaridou, I................................................. 934 Tebbe, U. ..................................................... 830 Thiemann, U. ............................................... 923 Thomann, P. A. ............................................ 923 Tigges, H........................................................ 55 Tigges, W....................................................... 55 Timmermann, L............................................ 221 Tölle, T. R..................................................... 160 Treede, R. -D ................................................ 115 Treib, J. ........................................................ 199 Trenkwalder, C. ........................................... 889 Treszl, A. ...................................... 807, 813, 826 Ulmer, S. ...................................................... 246 Urban, P. P. ......................................... 346, 296 Utpadel, D. .................................................. 160 van Elst, L. T. ............................................... 498 Van Gelder, I. C. .......................................... 791 Vance, W. N................................................. 896 Villringer, A. ................................................ 404 Vogel, S. T. .................................................. 231 Voth, I.......................................................... 160 Walitza, S. ................................................... 530 Walter, H. .................................................... 198 Warnke, C. .................................................. 721 Weber, Y. G. ................................................ 263 Wegscheider, K. .......................... 807, 813, 826 Welker, H. ................................................... 615 Wells, A. ...................................................... 316 Wettach, R. ................................................. 530 Wettermann, A. ....................................... 30, 36 Wiendl, H. ................................................... 721 Wiewrodt, D. ............................................... 634 Wilhelm, J. .................................................. 305 Willems, S. .................................................. 830 Willenborg, B. ............................................... 55 Winter, L...................................................... 316 Witt, K. ........................................................ 221 Woitalla, D. ................................................. 909 Wolf, N. D. .................................................. 164 Wolf, R. C. ................................................... 923 Woopen, C. ................................................. 221 Wössner, R. ................................................. 199 Zellerhoff, S. ................................................ 813 Zellmann, H. ................................................ 530 Ziegler, D. .................................................... 140 Zierz, S. ....................................................... 693 XIV http://www.nervenheilkunde-online.de
